About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Melatonin for Migraine Prevention | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00849511

Melatonin for Migraine Prevention

The circadian system with its centre in the hypothalamus is involved in migraine pathophysiology. Whether it plays a pivotal role is not clarified. The investigators postulate that a destabilized circ...

Lead sponsor: Nordlandssykehuset HF•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Nordlandssykehuset HF

Collaborators

University of Tromso

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients between 18 and 65 years, both male and females.
•Migraine present for at least 1 year and fulfilling diagnostic criteria that conform to those of the International Headache Society (HIS) \[2\] but otherwise healthy.
•Attacks of migraine should occur 4-6 times per month, there should be no regular use of other drugs, and the patient has to be able to differentiate between migraine headache and non-migrainous headache.
•Preventive drugs for migraine should not have been used the last three months.
•Conventional acute attack treatment is accepted, but not sporadic use of other drugs like hypnotics and anxiolytics.
•Residence of North-Norway.

Exclusion Criteria

•Medication overuse headache, chronic migraine.
•Pregnant and breast feeding women.
•Patient with either serious co-morbidity or conditions requiring medical treatment or caution.
•Psychiatric disease.

Related studies

RECRUITINGPhase 3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

NCT06810505 · Chronic Migraine

RECRUITINGPhase 3

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06241313 · Migraine

RECRUITINGPhase 3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

NCT07018713 · Chronic Migraine

A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine

NCT07454798 · Migraine, Headache Disorders, Primary

MMA Embolization for Refractory Chronic Migraine

NCT06735833 · Migraine

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 25, 2014Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment48

Start dateFeb 2009

Last updatedSep 25, 2014

Condition

Locations shown

Departement of Neurology, NLSH HF

Bodø

Departement of Neurology

Tromsø

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions